Development of 11-DGA-3-O-Gal-Modified Cantharidin Liposomes for Treatment of Hepatocellular Carcinoma. | |
Zhou, Lili; Zou, Manshu; Zhu, Kun; Ning, Shuangcheng; Xia, Xinhua* | |
刊名 | Molecules (Basel, Switzerland) |
2019 | |
卷号 | 24期号:17 |
关键词 | 3-galactosidase-30-stearyl deoxyglycyrrhetinic acid asialoglycoprotein receptor cantharidin glycyrrhetinic acid hepatocellular carcinoma targeted liposomes |
DOI | 10.3390/molecules24173080 |
URL标识 | 查看原文 |
WOS记录号 | WOS:000488613700060 |
内容类型 | 期刊论文 |
URI标识 | http://www.corc.org.cn/handle/1471x/5709199 |
专题 | 湖南中医药大学 |
作者单位 | 1.[Xia, Xinhua 2.Zhou, Lili 3.Zou, Manshu 4.Ning, Shuangcheng 5.Zhu, Kun] Hunan Univ Chinese Med, Sch Pharm, Changsha 410208, Hunan, Peoples R China. |
推荐引用方式 GB/T 7714 | Zhou, Lili,Zou, Manshu,Zhu, Kun,et al. Development of 11-DGA-3-O-Gal-Modified Cantharidin Liposomes for Treatment of Hepatocellular Carcinoma.[J]. Molecules (Basel, Switzerland),2019,24(17). |
APA | Zhou, Lili,Zou, Manshu,Zhu, Kun,Ning, Shuangcheng,&Xia, Xinhua*.(2019).Development of 11-DGA-3-O-Gal-Modified Cantharidin Liposomes for Treatment of Hepatocellular Carcinoma..Molecules (Basel, Switzerland),24(17). |
MLA | Zhou, Lili,et al."Development of 11-DGA-3-O-Gal-Modified Cantharidin Liposomes for Treatment of Hepatocellular Carcinoma.".Molecules (Basel, Switzerland) 24.17(2019). |
个性服务 |
查看访问统计 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论